Consistent with the first published results [17] for part of the series, patients with hepatic decompensation had a higher tumor volume (374 ± 84 mL vs. 304 ± 68 mL, p = 0.008), as well as higher bilirubin levels (0.7 ± 0.8 mg/dL vs. 1.4 ± 1.2 mg/dL, p = 0.022) and lower albumin levels (3.9 ± 0.8 g/dL vs. 3.3 ± 1.2 g/dL, p = 0.015). The gene discussed is ALB; the disease is neoplasm.